Cargando…
Prolonged Prophylactic Protection from Botulism with a Single Adenovirus Treatment Promoting Serum Expression of a VHH-Based Antitoxin Protein
Current therapies for most acute toxin exposures are limited to administration of polyclonal antitoxin serum. We have shown that VHH-based neutralizing agents (VNAs) consisting of two or more linked, toxin-neutralizing heavy-chain-only V(H) domains (VHHs), each binding distinct epitopes, can potentl...
Autores principales: | Mukherjee, Jean, Dmitriev, Igor, Debatis, Michelle, Tremblay, Jacqueline M., Beamer, Gillian, Kashentseva, Elena A., Curiel, David T., Shoemaker, Charles B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149568/ https://www.ncbi.nlm.nih.gov/pubmed/25170904 http://dx.doi.org/10.1371/journal.pone.0106422 |
Ejemplares similares
-
A Tetraspecific VHH-Based Neutralizing Antibody Modifies Disease Outcome in Three Animal Models of Clostridium difficile Infection
por: Schmidt, Diane J., et al.
Publicado: (2016) -
A Novel Strategy for Development of Recombinant Antitoxin Therapeutics Tested in a Mouse Botulism Model
por: Mukherjee, Jean, et al.
Publicado: (2012) -
Efficacy of equine botulism antitoxin in botulism poisoning in a guinea pig model
por: Emanuel, Andrew, et al.
Publicado: (2019) -
Cost savings associated with timely treatment of botulism with botulism antitoxin heptavalent product
por: Anderson, Deborah M., et al.
Publicado: (2019) -
Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques
por: Kodihalli, Shantha, et al.
Publicado: (2017)